HIGHLIGHTS
- who: Sacha Sarfati and colleagues from the Department of Pharmacology, Normandie University have published the article: Therapeutic Drug Monitoring of Sputum Voriconazole in Pulmonary Aspergillosis, in the Journal: Pharmaceutics 2022, 14, 1598. of /2022/
- what: The aim of this study was to evaluate the feasibility and utility of TDM of the voriconazole concentration in the sputum of patients treated for pulmonary aspergillosis. In the study , sputum samples were collected during induced coughing by a respiratory physiotherapist. Another limitation of the study was that the authors used Bartlett's criteria to ensure minimal saliva contamination of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.